RA CAPITAL MANAGEMENT, L.P. sold 16.0% of their position (30.32K shares) of SIONNA THERAPEUTICS, INC. on the open market
Open‑market sale worth $1.20M — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
Common Stock
Shares
−150.00
Price / share
$39.89
Trade value
$5.98K
% of position
Common Stock
Shares
−1.24K
Price / share
$39.89
Trade value
$49.26K
% of position
Common Stock
Shares
−801.00
Price / share
$39.89
Trade value
$31.95K
% of position
Common Stock
Shares
−947.00
Price / share
$39.89
Trade value
$37.78K
% of position
Common Stock
Shares
−96.00
Price / share
$40.50
Trade value
$3.89K
% of position
Common Stock
Shares
−788.00
Price / share
$40.50
Trade value
$31.91K
% of position
Common Stock
Shares
−512.00
Price / share
$40.50
Trade value
$20.74K
% of position
Common Stock
Shares
−604.00
Price / share
$40.50
Trade value
$24.46K
% of position
Common Stock
Shares
−1.21K
Price / share
$39.50
Trade value
$47.80K
% of position
Common Stock
Shares
−9.92K
Price / share
$39.50
Trade value
$392K
% of position
Common Stock
Shares
−6.44K
Price / share
$39.50
Trade value
$254.38K
% of position
Common Stock
Shares
−7.61K
Price / share
$39.50
Trade value
$300.56K
% of position
Net shares
−30.32K
Net value
-$1.20M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 11/20/2025 | S · Sale | −150.00 | $39.89 | $5.98K | 0.0% | 6.90M | 6.90M |
| Common Stock Indirect | 11/20/2025 | S · Sale | −1.24K | $39.89 | $49.26K | 0.2% | 662.25K | 661.02K |
| Common Stock Indirect | 11/20/2025 | S · Sale | −801.00 | $39.89 | $31.95K | 0.0% | 2.21M | 2.21M |
| Common Stock Indirect | 11/20/2025 | S · Sale | −947.00 | $39.89 | $37.78K | 0.6% | 168.19K | 167.25K |
| Common Stock Indirect | 11/20/2025 | S · Sale | −96.00 | $40.50 | $3.89K | 0.0% | 6.90M | 6.90M |
| Common Stock Indirect | 11/20/2025 | S · Sale | −788.00 | $40.50 | $31.91K | 0.1% | 661.02K | 660.23K |
| Common Stock Indirect | 11/20/2025 | S · Sale | −512.00 | $40.50 | $20.74K | 0.0% | 2.21M | 2.20M |
| Common Stock Indirect | 11/20/2025 | S · Sale | −604.00 | $40.50 | $24.46K | 0.4% | 167.25K | 166.64K |
| Common Stock Indirect | 11/21/2025 | S · Sale | −1.21K | $39.50 | $47.80K | 0.0% | 6.90M | 6.90M |
| Common Stock Indirect | 11/21/2025 | S · Sale | −9.92K | $39.50 | $392K | 1.5% | 660.23K | 650.31K |
| Common Stock Indirect | 11/21/2025 | S · Sale | −6.44K | $39.50 | $254.38K | 0.3% | 2.20M | 2.20M |
| Common Stock Indirect | 11/21/2025 | S · Sale | −7.61K | $39.50 | $300.56K | 4.6% | 166.64K | 159.03K |
| Total | −30.32K | -$1.20M | ||||||